U.S. Government Requests for Applications & Other U.S.-Based Funding Opportunities for Type 1 Diabetes Researchers

TEDDY RFP on Gene Expression

View the PDF for additional information

NIDDK has launched a new RFA

Bioengineering Interdisciplinary Training and Education for Type I Diabetes Research (T90/R90)

LOI Due Date: February 14, 2012
Application Due Date: March 14, 2012

Purpose: to promote the development of an interdisciplinary workforce for conducting bioengineering research to develop innovative technologies for treatment of type 1 diabetes including creating integrated long term glucose regulated insulin delivery systems (artificial pancreas), beta cell or islet encapsulation for beta cell replacement therapy, and/or beta cell and autoimmunity imaging methods. This FOA will support institutional training and education programs in type 1 diabetes research for postdoctoral level researchers with backgrounds in bioengineering and/or computational sciences.

TEDDY RFP on Viral Metagenomics and Microbiome

View the PDF for additional information

NIDDK RFAs with upcoming deadlines

Small Business Innovation Research to Develop New Methods and Technologies able to Identify Individuals at Risk of Developing Type 1 Diabetes [T1D] (R43)
LOI Due Date: November 22, 2011
Application Due Date: December 22, 2011

Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas [(SBIR) (R43/R44)]
LOI Due Date: October 26, 2011
Application Due Date: November 23, 2011

Improving Adherence in Pre-teens, Adolescents and Young Adults with Type 1 Diabetes (DP3)
LOI Due Date: February 2, 2012
Application Due Date: March 2, 2012

Function of Type 1 Diabetes Genes (DP3)
LOI Due Date: February 1, 2012
Application Due Date: February 29, 2012

TEDDY RFP on Dietary Biomarkers in T1D

View the PDF for additional information

TEDDY RFP on Metabolomics in T1D

View the PDF for additional information

NIDDK funding opportunities are now active:

Note: that the first two use the new Type 1 Diabetes Statutory Appropriation funding. See the following links for more information:

International Requests for Applications

Euro-BioImaging Proof-of-Concept Studies: CALL for USERS open now! (Oct. 1st to Nov.15th, 2011)

Albert Renold Fellowships supported by Merck Sharp & Dohme (MSD)
Available throughout the year